Pathology/Lab Coding Alert

ICD-10:

V84.0x Involves Simple ICD-10 Crosswalk

Apply the same BRCA positive rules when the codes change. You won't see "BRCA" in any code definition for ICD-9 or ICD-10, but you will see a one-to-one correspondence in the code sets for reporting this and other genetic mutations that lead to neoplasm susceptibility. Don't miss: The ICD-10 implementation deadline is shifting from Oct. 1, 2013. Read more about it in "Delay Gives You More Time to Implement ICD-10, HHS Confirms "on page xxx in this issue. Compare ICD-9, ICD-10 Genetic Susceptibility Certain mutations in the BRCA-1 and BRCA-2 genes can lead to increased breast and ovarian cancer risk in women. Here's how the two code set options compare for BRCA positive results: ICD-9: Under ICD-9, you should use one of the following codes: V84.01 -- Genetic susceptibility to malignant neoplasm of breast V84.02 -- Genetic susceptibility to malignant neoplasm of ovary ICD-10: Your ICD-10 options offer up familiar terms: Z15.01 -- [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Pathology/Lab Coding Alert

View All